In conclusion, the results of this multi-center prospective study suggest that rs2306283 (GA/AA) of SLCO1B1 in combination with rs1051266 (GG) of SLC19A1 are significantly associated with rapid tumor response to FOLFIRI/mCapeIRI in Chinese mCRC patients. Here, SLCO1B1 is linked to neoplasm.